US20040133079A1 - System and method for predicting patient health within a patient management system - Google Patents

Abstract

Systems and Methods for predicting patient health and patient relative well-being within a patient management system are disclosed. A preferred embodiment utilizes an implantable medical device comprising an analysis component and a sensing component further comprising a three-dimensional accelerometer, a transthoracic impedance sensor, a cardio-activity sensor, an oxygen saturation sensor and a blood glucose sensor. Some embodiments of a system disclosed herein also can be configured as an Advanced Patient Management System that helps better monitor, predict and manage chronic diseases.

Description

TECHNICAL FIELD
• The present system relates generally to a Patient Management System and particularly, but not by way of limitation, to such a system that can determine patient health, relative well-being and predictive degradation by using the sensing functions of an implantable medical device and analyzing the sensed patient data to predict patient health.[0001]
BACKGROUND
• Implantable medical devices are becoming increasingly versatile and able to perform many different physiological sensing functions that enable a clinician to quickly and accurately assess patient health. Traditionally, an accurate assessment of patient health required the clinician to synthesize often divergent or seemingly unrelated indications of patient health. For example, a diagnosis of congestive heart failure might include not only an assessment and evaluation of cardiac function data, but also an evaluation of other physiological factors like patient fatigue or respiration data.[0002]
• Typically, a clinician will assess patient health by inquiring how the patient feels or asking about the patient's activities and then make an indirect assessment based on the patient's response and the clinician's observation of the patient's appearance. However, these measures are very subjective and are limited to the time of the patient/clinician interaction and the quality of patient recall or willingness to divulge information. These factors affect the quality of the assessment.[0003]
• Modern implantable medical devices offer objective data to help the clinician assess patient health. Modern medical devices can sense and analyze physiological factors with improved accuracy and report that sensed and analyzed information to the clinician or the patient. The data or information that a medical device reports in the form of a sensed physiological parameter can be characterized as either derived or non-derived data. Non-derived data can be understood as raw biometric information sensed by the medical device that has not been processed to any meaningful degree. For example, non-derived biometric information may comprise the quantified measurement of a patient's heart rate or blood pressure. In contrast, derived data is biometric information that has been analyzed and perhaps assigned some qualitative or quantitative value. For example, as a medical device senses a patient's cardiac cycle and clinically analyzes that information, the medical device may report that an arrhythmia has occurred as the result of sensing and analyzing a cardiac rhythm outside expected parameters. Other derived sensors may include, the cumulative calories burned by daily activity, a weight loss monitor, a participation in activities monitor, a depression monitor or determining the onset of cancer, all of which may be ascertained by sensing physiological data and analyzing that data by using clinically derived algorithms or other analytical tools.[0004]
• An example of a sensor component of a medical device is an accelerometer. An accelerometer is essentially a device capable of measuring an object's relative orientation in a gravity field. It can directly sense patient movement (non-derived data) and present that information for analysis and perform as a derived sensor. Such derived information might include whether a patient is fatigued by reason of illness or because of overexertion. Thus, relative activity may correspond to relative patient health. In addition to simply determining whether a patient is ambulatory, a sensitive or finely-tuned accelerometer can also determine a patieht's relative position, i.e., whether the patient is sitting, standing, sleeping or distinguish whether the patient is prone because he decided to lie down instead of abruptly falling down. A sensitive accelerometer can also detect fine body movement, like the physical reflexes of a person coughing or sneezing.[0005]
• Coughing is often more than an indication of a respiratory irritation or condition like asthma or the onset of the common cold, but may also be a common side effect of certain drugs. For example, Angiotensin Converting Enzyme (“ACE”) inhibitors may cause a patient to cough when the patient's dosage is too high. Thus, coughing may be used to titrate the appropriate dose of a drug like an ACE inhibitor.[0006]
• Implantable medical devices comprising cardio-sensors, i.e., pacemakers, can also monitor and sense a patient's cardiac activity and provide remedial therapy. In addition, such medical devices can sense and measure transthoracic impedance as a means to evaluate patient respiration data.[0007]
• As a measurement of respiration, modern implantable medical devices often employ a sensor that measures transthoracic impedance. Transthoracic impedance is essentially the measure of a voltage across some known spacing or distance. To measure this voltage, the medical device drives a current from the device to the tip of a lead and voltage is measured from another area proximate to the device and another area proximate to the lead. For example, as a person's heart pumps, the transthoracic impedance changes because the heart is moving relative to the implanted device. Similarly, as a person's lung inflates and deflates as he breathes, the geometry of the current flowing between the device and the tip of the lead changes. In measuring respiration, the spacing or distance is situated in such a way that the distance crosses over either a person's left or right lung. Thus, when the geometry changes, the resistance also changes. In the context of breathing, the periodicity of the resistance also can serve as an indication of the relative depth or shallowness of breathing. In other words, a transthoracic impedance sensor can determine the symmetrical relationship between inhalation and exhalation. The symmetry of inhalation to exhalation can establish a pattern of respiration that may have clinical meaning, like determining asthma, apnea or chronic obstructive pulmonary disease (“COPD”). Within the context of detecting an asthma attack, a symmetrical breathing pattern recognized by a transthoracic impedance monitor may comprise the forced expiratory volume over one second (“FEV1”). Modern medical devices that measure transthoracic impedance can be configured to filter out the cardiac component and other impedance noise and concentrate on measuring the breathing component.[0008]
• An implantable medical device may also employ a sensor that measures blood glucose levels. In this way, the medical device may predict the need for insulin therapy before the patient or clinician observes acute symptoms of hyperglycemia.[0009]
• However, the data sensed by modern implantable medical devices is often presented in a form that merely reduces the data to some numerical or relative value that requires the clinician to further analyze the numerical or relative value output to make a meaningful clinical assessment. In addition, current implantable medical devices frequently are not analytically robust enough to provide meaningful diagnostic assessments or predictions of patient health beyond the mere reporting of physiological data. Merely reporting physiological data can be of limited value due to a person's natural ability to initially compensate for nascent changes in health status. Because of such analytical and perceptual limitations, sensing cardiac activity or transthoracic impedance data through a single implantable medical device may only provide the clinician with a useful starting point for further clinical analysis.[0010]
• Thus, for these and other reasons, there is a need for a Patient Management System comprising an implantable medical device further comprising various physiological sensors that sense and report patient data. The system is further adapted to analyze the sensed data in a manner that yields an accurate assessment or prediction of patient health or relative well-being. In this way, the system can be configured to not only report a relative state of patient health and detect early stage disease progression, but also alert the clinician to patient health degradation before the onset of an acute episode or symptomatic illness.[0011]
SUMMARY
• According to one aspect of the invention, there is provided a system and method for predicting patient health and relative well-being within a Patient Management System using an implantable medical device configured with multiple physiological sensors in communication with other components of the system via a communications network.[0012]
• The Patient Management System further includes an analytical component contained within the medical device or outside the device or a combination of internal and external analytical components. A non-limiting example of such an analytical component is an externally-based Advanced Patient Management System. As used herein, “physiological function data,” “physiology data,” “patient data” and “patient health data” are substantively synonymous terms and relate to a measurable or relative physiological parameter. In addition to physical parameters like heart rate, respiration and blood chemistry, physiological parameters may include, for example, subjective evaluations of well-being, perceived emotional state and other psychological attributes. Also, as used herein, a “clinician” can be a physician, physician assistant (PA), nurse, medical technologist, or any other patient health care provider.[0013]
• In one embodiment of a system for predicting patient health and relative well-being within a patient management system, the system comprises a medical device further comprising a sensing component, an analysis component and a communications component. The sensing component includes one or more base sensors adapted to sense physiological function data. The analysis component is adapted to analyze physiological data sensed by the sensing component and detect subtle, early indications of changes in disease state. The communications component is adapted to communicate sensed and analyzed physiological data to the components of the system.[0014]
• In another embodiment of the system for predicting patient health and relative well-being within a patient management system, the medical device comprising sensing, analysis and communications components is implanted within a patient, and the sensing component includes an accelerometer. The accelerometer can be configured to detect a patient's fine and gross body motion, and can be a one-, two- or three-dimensional accelerometer. Example analysis includes detecting changes in measured accelerometer patterns that are indicative of early occurrence of a new disease state or onset of illness or indicate progression of a disease.[0015]
• In a further embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer and a transthoracic impedance sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion and respiration parameters. Example analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of early occurrence of a new disease state (such as COPD) or onset of illness (such as asthma) or indicate progression of a disease (such as DC impedance indicating lung fluid accumulation which corresponds to progression of heart failure). Further, the sensed data can be used in combination to cross-validate sensed conclusions, such as a change in accelerometer data pattern coincident with inhalation/exhalation time ratio measured by transthoracic impedance to indicate progression of asthma.[0016]
• In yet another embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer, a transthoracic impedance sensor and a cardio-activity sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, and cardiac-activity parameters. Example analysis includes monitoring left and right intracardial R-wave amplitude and either singly reporting changes or correlating changes with changes in accelerometer and transthoracic impedance to form an early and confident indication of onset of pulmonary edema.[0017]
• In yet a further embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises an accelerometer, a transthoracic impedance sensor, and an oxygen saturation sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, cardiac-activity parameters and blood gas data. Example analysis includes combining changes in accelerometer and transthoracic impedance with blood oxygen saturation to form an early and confident indication of onset or progression of pulmonary edema.[0018]
• In a preferred embodiment of the system for predicting patient health and relative well-being within a patient management system, the sensing component of the implantable medical device comprises a three-dimensional accelerometer, a transthoracic impedance sensor, a cardio-activity sensor, an oxygen saturation sensor and a blood glucose sensor. In this embodiment, the implantable medical device is adapted to detect a patient's fine and gross body motion, respiration parameters, cardiac-activity parameters, blood gas data and episodes of hyper- and hypoglycemia. Example analysis includes combining changes in accelerometer data, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose for an early and confident indication of onset and changes in cardiac and pulmonary disease states.[0019]
• By selecting other base sensors, early and confident indications of onset or progression of diseases beyond cardiopulmonary can be made. By way of non-limiting example only, other base sensors might include a cardiac output/ejection fraction sensor; a chamber pressure sensor; a temperature sensor; sodium, potassium, calcium and magnesium sensors; a pH sensor; a partial oxygen sensor; a partial CO2 sensor; a cholesterol and triglyceride sensor; a catecholamine sensor; a creatine phosphokinase sensor; a lactate dehydrogenase sensor; a troponin sensor; a prothrombin time sensor; a complete blood count sensor; a blood urea nitrogen sensor; a body weight sensor; a blood (systemic) pressure sensor; a adrenocorticotropic hormone sensor; a thyroid marker sensor; a gastric marker sensor and a creatinine sensor. Data from these sensors can be analyzed to predict or detect, by way of non-limiting example only, the early onset of stroke, pain quantification/determination, chronic depression, cancer tissue (onset, progression, recurrence), syncope, autonomic tone, myocardial infarct, ischemia and seizure.[0020]
• The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Those skilled in the art will readily recognize various modifications and changes that may be made to the present invention without following the example embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the present invention, which is set forth in the following claims.[0021]
BRIEF DESCRIPTION OF THE DRAWINGS
• In the drawings, which are not necessarily drawn to scale, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.[0022]
• FIG. 1 is a schematic/block diagram illustrating generally, among other things, one embodiment of the system and method for predicting patient health within a patient management system.[0023]
• FIG. 2 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer.[0024]
• FIG. 3 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer and a transthoracic impedance sensor.[0025]
• FIG. 4 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor and an oxygen saturation sensor.[0026]
• FIG. 5 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor and a cardio-activity sensor.[0027]
• FIG. 6 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within a patient management system comprising an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor, a cardio-activity sensor and a blood glucose sensor.[0028]
• FIG. 7 is a schematic/block diagram illustrating generally, among other things, another embodiment of the system and method for predicting patient health within an Advanced Patient Management system.[0029]
• FIG. 8 is a flow diagram illustrating generally, among other things, the interactive functions of the system and method for predicting patient health within a patient management system.[0030]
DETAILED DESCRIPTION
• In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration, specific embodiments or examples. These embodiments may be combined, other embodiments may be utilized, and structural, logical and electrical changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.[0031]
• The present system and method are described with respect to an implantable medical device as a component of a Patient Management System capable of predicting patient health and relative well-being by the comprehensively analyzing sensed physiological data.[0032]
• FIG. 1 is a schematic/block diagram illustrating generally an embodiment of the system and method for predicting patient health and relative well-being within a[0033]patient management system100. The system comprises a medical device further comprising asensing component101, ananalysis component102 and acommunications component103. The medical device can be implantable104 within apatient105.
• The[0034]sensing component101 includes one or more sensors adapted to sense physiological data. The sensors may comprise an accelerometer, a transthoracic impedance sensor, an oxygen saturation sensor, and a cardio-activity sensor.
• The[0035]analysis component102 is adapted to analyze physiological data sensed by the sensing component. Analysis may be internal and/or external to the patient. Analysis may include the use of clinically derived algorithms to analyze the biometric data in a way that yields a clinically relevant output. The algorithms can be the result of the extraction, codification and use of collected expert knowledge for the analysis or diagnosis of medical conditions. For example, the algorithms can comprise institutional analytical or diagnostic techniques used in specific clinical settings. By reducing the analytical or diagnostic methodologies of institutions like the Cleveland Clinic, the Mayo Clinic or the Kaiser Permanente system to algorithmic expression, a patient will enjoy the benefit of the medical expertise of a leading medical institution without having to visit the institution. The analysis and sensing components are further adapted to electronically communicate with the communications component.
• The[0036]communications component103 is adapted to communicate sensed and analyzed physiological data to the components of the system, whether the components are internal or external to the patient.
• FIG. 2 is a schematic/block diagram illustrating generally an embodiment of the[0037]accelerometer200 component of the system and method for predicting patient health and relative well-being within a patient management system. Theaccelerometer200 can be configured to detect a patient's fine and gross body motion. A suitable accelerometer includes a one-dimensional, two-dimensional200 or three-dimensional accelerometer. Typically, a one-dimensional accelerometer only measures movement along asingle axis201 as further illustrated in FIG. 2. A two-dimensional accelerometer typically measures movement along twoorthogonal axes202. A three-dimensional accelerometer measures movement along threeorthogonal axes203. When the system comprises a three-dimensional accelerometer, the system can determine person's body position with greatest accuracy. Thus, in addition to detecting gross body movement, a sensitive accelerometer may be adapted to detect fine body movement, like a person coughing. When the system is configured to analyze accelerometer data to determine whether a person is coughing, a clinician can utilize that derivative information two assist in determining the onset of a common cold, influenza or the proper dosage of a drug, like an ACE inhibitor, that may cause a coughing side effect when the dosage is too high. In addition, coughing or other activity sensed by theaccelerometer200 may be used to titrate the dosage of other drugs as a component of a near-term drug delivery system, wherein the titration analysis is communicated to the patient or the clinician.
• FIG. 3 is a schematic/block diagram illustrating generally an embodiment of the[0038]transthoracic impedance sensor300 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 3, thetransthoracic impedance sensor300 is a component of an implantablemedical device301. In this embodiment, the implantable medical device comprises anaccelerometer200 as illustrated in FIG. 2 and atransthoracic impedance sensor300. Atransthoracic impedance sensor300 may be adapted to sense impedance changes in the heart or lungs or both. The transthoracic impedance sensor can be configured to filter out the cardiac component and other impedance noise and focus on respiration measurement. In such a filtered embodiment, thetransthoracic impedance sensor300 can assist the clinician in predicting the onset or presence of an asthma attack, apnea, COPD and FEV1. Further, in this embodiment, thetransthoracic impedance sensor300 may also be configured to detect the accumulation of fluid in the lungs. Such detection may also serve to predictively indicate the onset or existence of pulmonary disease.
• FIG. 4 is a schematic/block diagram illustrating generally an embodiment of the[0039]oxygen saturation sensor400 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 4, theoxygen saturation sensor400 is a component of an implantablemedical device301. In this embodiment, the implantable medical device comprises anaccelerometer200 as illustrated in FIG. 2, atransthoracic impedance sensor300 and anoxygen saturation sensor400. Anoxygen saturation sensor400 determines the ratio between the deoxygenated hemoglobin and oxygenated hemoglobin. In a healthy person, breathing air at sea level, the level of saturation is between 96% and, 98%. Abnormal levels may indicate a respiratory or environmental problem. When combined with other measurements of patient health, a patient's oxygen saturation level may provide further evidence of patient health or relative well-being.
• FIG. 5 is a schematic/block diagram illustrating generally an embodiment of the cardio-[0040]activity sensor500 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 5, the cardio-activity sensor500 is a component of an implantablemedical device301. In this embodiment, the implantable medical device comprises anaccelerometer200 as illustrated in FIG. 2, atransthoracic impedance sensor300, anoxygen saturation sensor400, and a cardio-activity sensor500. The cardio-activity sensor500 may be configured to detect cardiac arrhythmias. Depending on the nature of the arrhythmia, the cardio-activity sensor500 may cause therapy to be directed to the patient in the form of a low energy electrical stimuli, i.e., pace pulse, or a defibrillation countershock. The cardio-activity sensor500 may also be used to signal a clinician that an arrhythmia requires further analysis or medical intervention. The cardio-activity sensor500 in this embodiment may also assist in predicting stroke by measuring ST-segment changes in an electrocardiogram and conveying that information to theanalysis component102 to confirm ST-segment elevations or abnormalities.
• FIG. 6 is a schematic/block diagram illustrating generally an embodiment of the[0041]blood glucose sensor600 component of the system and method for predicting patient health and relative well-being within a patient management system. In one embodiment, as illustrated in FIG. 6, theblood glucose sensor600 is a component of an implantablemedical device301. In this embodiment, the implantable medical device comprises anaccelerometer200 as illustrated in FIG. 2, atransthoracic impedance sensor300, anoxygen saturation sensor400, a cardio-activity sensor500 and ablood glucose sensor600. Theblood glucose sensor600 may be configured to detect elevations or de-elevations in blood glucose. Depending on the nature of the blood glucose level, theblood glucose sensor600 may cause therapy to be directed to the patient in the form of insulin administration or be used to signal an alert to the patient or clinician.
• FIG. 7 is a schematic/block diagram illustrating generally an embodiment of the system and method for predicting patient health and relative well-being within a[0042]patient management system100 illustrating the analysis of patient data by an externally-based Advanced Patient Management System (“APM”)700.
• APM is a system that helps patients, their physicians and their families to better monitor, predict and manage chronic diseases. In the embodiment shown in FIG. 7, the APM system[0043]700 consists of three primary components: 1) an implantablemedical device301 with sensors adapted to monitor physiological data, 2) a Data Management System (“DMS”)701, adapted to process and store patient data701acollected from the sensors, patient population data701b, medical practice data601cfurther comprising clinically derived algorithms, andgeneral practice data701d, and 3) ananalytical engine702 adapted to analyze data from the DMS. APM is designed to support physicians and other clinicians in using a variety of different devices, patient-specific and non-specific data, along with medication therapy, to provide the best possible care to patients. Currently, implanted devices often provide only limited sensing, analysis and therapy to patients. APM moves the device from a reactive mode into a predictive one that allows a clinician to use APM to predict patient health.
• FIG. 8 is a flow diagram illustrating generally the interactive functions of the system and method for predicting patient health and relative well-being within a[0044]patient management system100. As illustrated in FIG. 8, thesensing800,analysis701 andcommunications802 components are interactive, thus allowing the components to communicate and share data. By way of non-limiting example only, thesensing component800 would first sense physiological function data from apatient105. Thesensing component800 may be further adapted to provide therapy to thepatient105. That data would then be transmitted toanalysis component801 for analysis. Analysis may comprise the use of clinically derived algorithms and may be performed internal and/or external to thepatient105. Based on the analysis, thesensing component800 may be further adapted to provide therapy to thepatient105. The analyzed data is then received bycommunications module802, which reports the analyzed data in the form of a determination of patient health or relative well-being to apatient105 or clinician105a. Thecommunications component802 may also be in communication with a patient management system, including an externally based AdvancedPatient Management system803. Communication can be in the form of wired or wireless electronic communication.
• The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Those skilled in the art will readily recognize various modifications and changes that may be made to the present invention without following the example embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the present invention, which is set forth in the following claims.[0045]
• It is to be understood that the above description is intended to be illustrative, and not restrictive. For example, the above-described embodiments may be used in combination with each other. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. In the appended claims, the terms “including,” “includes” and “in which” are used as the plain-English equivalents of the respective terms “comprising,” “comprises” and “wherein.”[0046]

Claims (101)

What is claimed is:

1. A system for predicting patient health and well-being within a patient management system comprising a medical device further comprising:

a. a sensing component in electronic communication with other components of the system including one or more sensors adapted to sense physiological function data;

b. an analysis component in electronic communication with other components of the system adapted to analyze the sensed physiological data; and

c. a communications component in electronic communication with other components of the system adapted to communicate the sensed or analyzed physiological data.

2. The medical device ofclaim 1, wherein the device is an implantable medical device.

3. The sensing component ofclaim 1, wherein the sensing component comprises an accelerometer.

4. The accelerometer ofclaim 3, wherein the accelerometer comprises a one-dimensional accelerometer.

5. The accelerometer ofclaim 3, wherein the accelerometer comprises a two-dimensional accelerometer.

6. The accelerometer ofclaim 3, wherein the accelerometer comprises a three-dimensional accelerometer.

7. The sensing component ofclaim 1, wherein the sensing component comprises a transthoracic impedance sensor.

8. The sensing component ofclaim 1, wherein the sensing component comprises a cardio-activity sensor.

9. The sensing component ofclaim 1, wherein the sensing component comprises an oxygen saturation sensor.

10. The sensing component ofclaim 1, wherein the sensing component comprises a blood glucose sensor.

11. The sensing component ofclaim 1, wherein the sensing component comprises a cardiac output/ejection fraction sensor.

12. The sensing component ofclaim 1, wherein the sensing component comprises a chamber pressure sensor.

13. The sensing component ofclaim 1, wherein the sensing component comprises a temperature sensor.

14. The sensing component ofclaim 1, wherein the sensing component comprises a sodium sensor.

15. The sensing component ofclaim 1, wherein the sensing component comprises a potassium sensor.

16. The sensing component ofclaim 1, wherein the sensing component comprises a calcium sensor.

17. The sensing component ofclaim 1, wherein the sensing component comprises a magnesium sensor.

18. The sensing component ofclaim 1, wherein the sensing component comprises a pH sensor.

19. The sensing component ofclaim 1, wherein the sensing component comprises a partial oxygen sensor.

20. The sensing component ofclaim 1, wherein the sensing component comprises a partial CO2 sensor.

21. The sensing component ofclaim 1, wherein the sensing component comprises a cholesterol sensor.

22. The sensing component ofclaim 1, wherein the sensing component comprises a triglyceride sensor.

23. The sensing component ofclaim 1, wherein the sensing component comprises a catecholamine sensor.

24. The sensing component ofclaim 1, wherein the sensing component comprises a creatine phosphokinase sensor.

25. The sensing component ofclaim 1, wherein the sensing component comprises a lactate dehydrogenase sensor.

26. The sensing component ofclaim 1, wherein the sensing component comprises a troponin sensor.

27. The sensing component ofclaim 1, wherein the sensing component comprises a prothrombin time sensor.

28. The sensing component ofclaim 1, wherein the sensing component comprises a complete blood count sensor.

29. The sensing component ofclaim 1, wherein the sensing component comprises a blood urea nitrogen sensor.

30. The sensing component ofclaim 1, wherein the sensing component comprises a body weight sensor.

31. The sensing component ofclaim 1, wherein the sensing component comprises a blood (systemic) pressure sensor.

32. The sensing component ofclaim 1, wherein the sensing component comprises a adrenocorticotropic hormone sensor.

33. The sensing component ofclaim 1, wherein the sensing component comprises a thyroid marker sensor.

34. The sensing component ofclaim 1, wherein the sensing component comprises a gastric marker sensor.

35. The sensing component ofclaim 1, wherein the sensing component comprises a creatinine sensor.

36. The accelerometer ofclaim 3, wherein the accelerometer is adapted to sense the fine and gross body position of a person.

37. The fine and gross body position ofclaim 36, wherein the sensed body position of the person comprises standing, sitting, lying on the back, lying on the stomach, lying upon the left side and lying on the right side.

38. The accelerometer ofclaim 3, wherein the accelerometer is adapted to sense the fine and gross body motion of a person.

39. The fine and gross body motion ofclaim 38, wherein the sensed body motion comprises a baseline measurement of patient activity.

40. The fine and gross body motion ofclaim 38, wherein the sensed body motion comprises a measure of well-being.

41. The fine and gross body motion ofclaim 38, wherein the sensed body motion comprises a measure of lethargy.

42. The measure of lethargy ofclaim 41, wherein the measure comprises the magnitude of activity and the frequency of activity.

43. The accelerometer ofclaim 3, wherein the accelerometer is adapted to detect a cough.

44. The detected cough ofclaim 43, wherein the cough is analyzed to detect the onset of a common cold.

45. The detected cough ofclaim 43, wherein the cough is analyzed to detect the onset of influenza.

46. The detected cough ofclaim 43, wherein the cough is analyzed to titrate a drug.

47. The titrated drug ofclaim 46, wherein the drug is an angiotensin converting enzyme inhibitor.

48. The titrated drug ofclaim 46, wherein the drug comprises a near-term drug delivery system.

49. The near-term drug delivery system ofclaim 48, wherein the system comprises communication with a clinician.

50. The near-term drug delivery system ofclaim 48, wherein the system comprises communication with a patient.

51. The analysis component ofclaim 1, wherein the analysis is performed internal to the patient.

52. The analysis component ofclaim 1, wherein the analysis is performed external to the patient.

53. The analysis component ofclaim 1, wherein the analysis is performed, in part, internal to the patient.

54. The analysis component ofclaim 1, wherein the analysis is performed, in part, external to the patient.

55. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of early occurrence of a new disease state.

56. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of onset of illness.

57. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed data patterns that are indicative of progression of a disease.

58. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of early occurrence of a new disease state.

59. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of onset of illness.

60. The analysis component ofclaim 1, wherein the analysis includes detecting changes in sensed accelerometer patterns that are indicative of progression of a disease.

61. The analysis component ofclaim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of early occurrence of a new disease state.

62. The new disease state ofclaim 61, wherein the new disease state is chronic obstructive pulmonary disease.

63. The analysis component ofclaim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that are indicative of onset of illness.

64. The onset of illness ofclaim 63, wherein the illness comprises asthma.

65. The analysis component ofclaim 1, wherein the analysis includes detecting changes in transthoracic impedance variation patterns that indicate progression of a disease.

66. The progression of disease ofclaim 65, wherein the disease comprises heart failure.

67. The analysis component ofclaim 1, wherein the analysis includes combining sensed data to cross-validate sensed conclusions.

68. The combined sensed data ofclaim 67, wherein the combined data includes a change in accelerometer data pattern coincident with inhalation/exhalation time ratio measured by transthoracic impedance.

69. The combined data ofclaim 68, wherein the combined data indicates progression of asthma.

70. The analysis component ofclaim 1, wherein the analysis includes monitoring left and right intracardial R-wave amplitude.

71. The analysis ofclaim 70, wherein the analysis includes singly reporting changes.

72. The analysis ofclaim 71, wherein the analysis comprises an early and confident indication of onset of pulmonary edema.

73. The analysis ofclaim 70, wherein the analysis includes correlating left and right intracardial R-wave amplitude data with accelerometer and transthoracic impedance data.

74. The analysis ofclaim 73, wherein the analysis comprises an early and confident indication of onset of pulmonary edema.

75. The analysis component ofclaim 1, wherein the analysis includes combining accelerometer, transthoracic impedance and blood oxygen saturation data to form an early and confident indication of onset of pulmonary edema.

76. The analysis component ofclaim 1, wherein the analysis includes combining accelerometer, transthoracic impedance and blood oxygen saturation data to form an early and confident indication of progression of pulmonary edema.

77. The analysis component ofclaim 1, wherein the analysis includes combining accelerometer, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose data for an early and confident indication of onset of cardiac and pulmonary disease states.

78. The analysis component ofclaim 1, wherein the analysis includes combining accelerometer, transthoracic impedance, blood oxygen saturation, cardio-activity and blood glucose data for an early and confident indication of changes in cardiac and pulmonary disease states.

79. The analysis component ofclaim 1, wherein the analysis includes combining data from other base sensors for an early and confident indication of onset of diseases other than cardio-pulmonary diseases.

80. The analysis component ofclaim 1, wherein the analysis includes combining data from other sensors for an early and confident indication of progression of diseases other than cardiopulmonary diseases.

81. The communications component ofclaim 1, wherein the communications are wired electronic communications.

82. The communications component ofclaim 1, wherein the communications are wireless electronic communications.

83. The communications component ofclaim 1, wherein the communications are a combination of wired and wireless electronic communications.

84. A method for predicting patient health and well-being within a patient management system comprising a medical device comprising the steps of:

a. sensing physiological function data with one or more sensor components in electronic communication with other components of the system and adapted to sense such data;

b. analyzing the sensed physiological data with an analysis component in electronic communication with other components of the system and adapted to analyze the sensed data; and

c. communicating the sensed and analyzed physiological data with a communications component in electronic communication with other components of the system and adapted to communicate the sensed and analyzed data to the components of the system.

85. The method ofclaim 84, wherein the step of sensing physiological function data comprises the further step of sensing a fine and gross body position of a person with an accelerometer.

86. The method ofclaim 84, wherein the step of sensing physiological function data comprises the further step of sensing respiration function data of a person with an transthoracic impedance sensor.

87. The method ofclaim 84, wherein the step of sensing physiological function data comprises the further step of sensing cardiac activity of a person with a cardio-activity sensor.

88. The method ofclaim 84, wherein the step of sensing physiological function data comprises the further step of oxygen saturation of a person with an oxygen saturation sensor.

89. The method ofclaim 84, wherein the step of sensing physiological function data comprises the further step of oxygen saturation of a person with a blood glucose sensor.

90. The method ofclaim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of early occurrence of a new disease state.

91. The method ofclaim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of onset of illness.

92. The method ofclaim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing changes in sensed data patterns that are indicative of progression of a disease.

93. The method ofclaim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing the sensed physiological function data by using clinically derived algorithms.

94. The step of analyzing sensed physiological function data ofclaim 93, wherein the step comprises the further step of analyzing the sensed physiological data by using algorithms reflecting a standard of medical care of a medical institution.

95. The method ofclaim 84, wherein the step of analyzing sensed physiological function data comprises the further step of analyzing the sensed physiological function data with an Advanced Patient Management system.

96. The method ofclaim 84, wherein the step of communicating the sensed and analyzed physiological function data comprises the further step of electronically communicating the sensed and analyzed data to other components of the system.

97. The method ofclaim 96, wherein the step of electronically communicating the sensed and analyzed physiological function data comprises the further step of wirelessly communicating the sensed and analyzed data.

98. The step of communicating the sensed and analyzed physiological function data ofclaim 96, wherein the step comprises the further step of communicating the sensed and analyzed data to a patient management system.

99. The step of communicating the sensed and analyzed physiological function data ofclaim 97, wherein the step comprises the further step of communicating the sensed and analyzed data to a patient management system.

100. The step of communicating the sensed and analyzed physiological function data ofclaim 96, wherein the step comprises the further step of communicating the sensed and analyzed data to an Advanced Patient Management system.

101. The step of communicating the sensed and analyzed physiological function data ofclaim 97, wherein the step comprises the further step of communicating the sensed and analyzed data to an Advanced Patient Management system.

Images